Skip to main content

A Real-Time Taqman® Method for Hepatitis C Virus Genotyping and Methods for Further Subtyping of Isolates

  • Protocol

Part of the book series: Methods in Molecular Biology™ ((MIMB,volume 510))

Abstract

The HCV genome is highly heterogeneous; more and more genotypes, each with several distinct subtypes, are being identified around the world. Knowledge of genotype is important for planning of treatment regimes, whereas subtype identification is useful in epidemiological studies and outbreak investigation. We describe HCV genotyping and subtyping assays, based on real-time PCR, that are sensitive, specific, and reliable. These assays provide fast, accurate, and convenient methods for HCV genotyping/subtyping to support clinical practice.

This is a preview of subscription content, log in via an institution.

Buying options

Protocol
USD   49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Springer Nature is developing a new tool to find and evaluate Protocols. Learn more

References

  1. Manns, M. P., McHutchison, J. G., Gordon, S. C., Rustqi, V. K., Shiffman, M., Reindollar, R., et al. (2001) Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for the initial treatment of chronic hepatitis C: a randomised trial. Lancet 358, 958–965.

    Article  CAS  PubMed  Google Scholar 

  2. Fried, M. W., Shiffman, N. L., Reddy, K. R., Smith, C., Marinos, G., Goncales, F. L., et al. (2002) Peginterferon alfa-2a plus ribavirin in patients with chronic hepatitis C virus infection. N. Eng. J. Med. 347, 975–982.

    Article  CAS  Google Scholar 

  3. Lee, S., Heathcote, E., Reddy, K., Zeuzem, S., Fried, M. W., Wright, T. L., et al. (2002) Prognostic factors and early predictability of sustained viral response with peginterferon alfa-2a. J. Hepatol. 37, 500–506.

    Article  CAS  PubMed  Google Scholar 

  4. Lee, S. S. and Abdo, A. A. (2003) Predicting antiviral treatment response in chronic hepatitis C: how accurate and how soon? J. Antimicrob. Chemoth. 51, 487–491.

    Article  CAS  Google Scholar 

  5. Hadziyannis, S. J., Sette, H., Jr., Morgan, T. R., Balan, V., Diago, M., Marcellin, P., et al. (2004) Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C: a randomised study of treatment duration and ribavirin dose. Ann. Intern. Med. 140, 346–355.

    CAS  PubMed  Google Scholar 

  6. National Institute of Clinical Excellence (NICE) guidelines (2004) Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of chronic hepatitis C. Technology Appraisal Guidance 75. Available at www.nice.org.uk.

  7. NICE guidelines (2006) Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C. Technology Appraisal Guidance 106. Available at http://www.nice.org.uk.

  8. Strader, D. B., Wright, T., Thomas, D. L., and Seeff, L. B. (2004) Diagnosis, management, and treatment of hepatitis C. Hepatology 39, 1147–1171.

    Article  PubMed  Google Scholar 

  9. Zein, N. N. (2000) Clinical significance of hepatitis C virus genotypes. Clin. Microbiol. Rev. 13, 223–235.

    Article  CAS  PubMed  Google Scholar 

  10. Maertens, G., and Stuyver, L. (1997) Genotypes and genetic variation of hepatitis, in The Molecular Medicine of Viral Hepatitis (Harrison, T. J. and Zuckerman, A., eds.), John Wiley and Sons, Chichester, England, pp. 183–233.

    Google Scholar 

  11. Takada, N., Takase, S., Takada, A., and Date, T. (1993) Differences in the hepatitis C virus genotypes in different countries. J. Hepatol. 17, 277–283.

    Article  CAS  PubMed  Google Scholar 

  12. Xu, L.-Z., Larzul, D., Delaporte, E., Bréchot, C., and Kremsdorf, D. (1994) Hepatitis C virus genotype 4 is highly prevalent in central Africa (Gabon). J. Gen. Virol. 75, 2393–2398.

    Article  CAS  PubMed  Google Scholar 

  13. Chamberlain, R. W., Adams, N., Saeed, A. A., Simmonds, P., and Elliott, R. M. (1997) Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East. J. Gen. Virol. 78, 1341–1347.

    CAS  PubMed  Google Scholar 

  14. Bullock, G. C., Bruns, D.E., and Haverstick, D.M. (2002) Hepatitis C genotype determination by melting curve analysis with a single set of fluorescence resonance energy transfer probes. Clin. Chem. 48, 2147–2154.

    CAS  PubMed  Google Scholar 

  15. Schröter, M., Zöllner, B., Schäfer, P., Landt, O., Lass, U., Laufs, R., et al. (2002) Genotyping of hepatitis C virus types 1, 2, 3, and 4 by a one-step LightCycler method using three different pairs of hybridization probes. J. Clin. Microbiol. 40, 246–250.

    Google Scholar 

  16. Lindh, M. and Hannoun, C. (2005) Genotyping of hepatitis C virus by Taqman real-time PCR. J. Clin. Virol. 34, 108–114.

    Article  CAS  PubMed  Google Scholar 

  17. Rolfe, K. J., Alexander, G. J. M., Wreghitt, T. G., Parmar, S., Jalal, H., and Curran, M. D. (2005) A real-time Taqman method for hepatitis C virus genotyping. J. Clin. Virol. 34, 115–121.

    Article  CAS  PubMed  Google Scholar 

  18. Chen, Z. and Weck, K. E. (2002) Hepatitis C genotyping: interrogation of the 5′ untranslated region cannot accurately distinguish genotypes 1a and 1b. J. Clin. Microbiol. 40, 127–134

    Google Scholar 

  19. Sandres-Sauné, K., Deny, P., Pasquier, C., Thibaut, C., Duverlie, G., and Izopet, J. (2003) Determining hepatitis C genotype by analyzing the sequence of the NS5b region. J. Virol. Methods 109, 187–193.

    Article  PubMed  Google Scholar 

  20. Othman, S. B., Trabelsi, A., Monnet, A., Bouzgarrou, N., Grattard, F., Beyou, A., Bourlet, T., and Pozzetto, B. (2004) Evaluation of a prototype HCV NS5b assay for typing strains of hepatitis C virus isolated from Tunisian haemodialysis patients. J. Virol. Methods 119, 177–181.

    Article  CAS  PubMed  Google Scholar 

  21. Amoroso, P., Rapicetta, M., Tosti, M. E., Mele, A., Spada, E., Buonocore, S., Lettieri, G., Pierri, P., Chionne, P., Ciccaglione, A. R., and Sagliocca, L. (1998) Correlation between virus genotype and chronicity rate in acute hepatitis C. J. Hepatol. 28, 939–944.

    Article  CAS  PubMed  Google Scholar 

  22. Nakano, I., Fukuda, Y., Katano, Y., Toyoda, H., Hayashi, K., Kumada, T., and Nakano, S. (2001) Japan-specific subtype of hepatitis C virus genotype 1b, J subtype, has relatively low pathogenicity. J. Med. Virol. 65, 45–51.

    Article  CAS  PubMed  Google Scholar 

  23. Wiese, M., Grungreiff, K., Guthoff, W., Lafrenz, M., Oesen, U. and Porst, H. (2005) Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany—a 25-year multicenter study. J. Hepatol. 43, 590–598.

    Article  PubMed  Google Scholar 

  24. Manesis, E. K., Papaioannou, C., Gioustozi, A., Kafiri, G., Koskinas, J., and Hadziyannis, S. J. (1997) Biochemical and virological outcome of patients with chronic hepatitis C treated with Interferon alfa-2b for 6 or 12 months: a 4-year follow-up of 211 patients. Hepatology 26, 734–739.

    Article  CAS  PubMed  Google Scholar 

  25. Nakano, I., Fukuda, Y., Katano, Y., Toyoda, H., Hayashi, K., Kumada, T., and Nakano, S. (2001) Interferon responsiveness in patients infected with hepatitis C virus 1b differs depending on viral subtype. Gut 49, 263–267.

    Article  CAS  PubMed  Google Scholar 

  26. Garson, J. A., Ring, C., Tuke, P., and Tedder, R. S. (1990) Enhanced detection by PCR of hepatitis C virus RNA. Lancet 336, 878–879.

    Article  CAS  PubMed  Google Scholar 

  27. Okamoto, H., Okada, S., and Sugiyama, Y. F. (1990) Detection of hepatitis C virus RNA by a two stage polymerase chain reaction with two pairs of primers from the 3′ non-coding region. Jpn. J. Exp. Med. 60, 215–222.

    CAS  PubMed  Google Scholar 

  28. Simmonds, P., Bukh, J., Combet, C., Deleage, G., Enomoto, N., Feinstone, S., et al. (2005) Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42, 962–973.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Humana Press, a part of Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Rolfe, K.J., Wreghitt, T.G., Alexander, G.J.M., Curran, M.D. (2009). A Real-Time Taqman® Method for Hepatitis C Virus Genotyping and Methods for Further Subtyping of Isolates. In: Tang, H. (eds) Hepatitis C. Methods in Molecular Biology™, vol 510. Humana Press. https://doi.org/10.1007/978-1-59745-394-3_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-394-3_5

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-970-3

  • Online ISBN: 978-1-59745-394-3

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics